Wang Yujia, Song Wenjie, Bao Lijun, Wei Junwu, Qian Yangyang, Bi Yunmei
College of Chemistry and Chemical Engineering, Yunnan Normal University Kunming 650500 China
RSC Adv. 2023 Jul 21;13(32):22079-22087. doi: 10.1039/d3ra03790h. eCollection 2023 Jul 19.
Stimuli-responsive linear-dendritic block copolymers (LDBCs) have attracted significant research attention as novel drug carriers. We report here three generations of new enzyme and pH dual responsive linear-dendritic block copolymers (LDBCs) with a phenylalanyl-lysine (Phe-Lys) dipeptide linking hydrophilic linear poly(-vinylpyrrolidone) (PNVP) and a hydrophobic peripherally ketal-functionalized dendron derived from 2,2'-bis(hydroxymethyl)propionic acid (bis-MPA). The LDBCs are synthesized a combination of interchange of xanthates/reversible addition-fragmentation chain transfer (MADIX/RAFT) polymerization of -vinylpyrrolidone (NVP) and "chain-first" strategy. Their structures are confirmed by H NMR spectra. The gel permeation chromatograph (GPC) analysis revealed that the LDBCs have a narrow molecular weight distribution (PDI ≤ 1.25). The amphiphilic LDBCs can self-assemble into spherical nanomicelles in aqueous solution. The presence of enzyme or/and the change of pH cause disassembly of micelles to release encapsulated cargos. The release rates of the guest molecules are faster in buffer solution at pH 5.0 than those upon the addition of the activating enzyme and can be fine-tuned by changing the generation of bis-MPA dendrons. The combination of enzyme and pH dual stimuli results in significantly accelerated and more complete release of the loaded hydrophobic guests. The cell viability assay confirmed the favorable biocompatibility until the LDBC micelle concentration reached 800 μg mL. These results indicate that the LDBCs can be considered as a good candidate for targeting drug delivery.
刺激响应性线性-树枝状嵌段共聚物(LDBCs)作为新型药物载体已引起了广泛的研究关注。我们在此报告了三代新型酶和pH双重响应性线性-树枝状嵌段共聚物(LDBCs),其通过苯丙氨酰-赖氨酸(Phe-Lys)二肽连接亲水性线性聚(乙烯基吡咯烷酮)(PNVP)和源自2,2'-双(羟甲基)丙酸(双-MPA)的疏水性外周缩酮官能化树枝状分子。LDBCs是通过N-乙烯基吡咯烷酮(NVP)的黄原酸酯交换/可逆加成-断裂链转移(MADIX/RAFT)聚合与“链先”策略相结合合成的。它们的结构通过1H NMR光谱得到证实。凝胶渗透色谱(GPC)分析表明,LDBCs具有窄的分子量分布(PDI≤1.25)。两亲性LDBCs在水溶液中可自组装成球形纳米胶束。酶的存在或/和pH的变化会导致胶束解体以释放包封的货物。客体分子在pH 5.0的缓冲溶液中的释放速率比添加激活酶时更快,并且可以通过改变双-MPA树枝状分子的代数进行微调。酶和pH双重刺激的组合导致负载的疏水性客体的释放显著加速且更完全。细胞活力测定证实,直到LDBC胶束浓度达到800μg/mL,其具有良好的生物相容性。这些结果表明,LDBCs可被视为靶向药物递送的良好候选者。